Consider that substances like ta65 may be a growth factor that causes cells with longer telomeres to divide more quickly. Thereby decreasing their average telomere length over time. While either having little effect or maybe even slowing down cell division in cells with the shorter telomeres. This would make the average telomere length for the short telomere group appear to increase over time relative to the long telomere group. While not necessarily increasing the overall average telomere length. Or impacting overall cell replacement needs.
I got the idea, btw, when I was trying to imagine how both average telomere length and the percentage of critically short telomeres could decline together and I got this image of a shrinking brontosaurus in my head. Thank you Dr. Anne Elk.
Howard
The idea seem logical enough. I suppose the theory to some extent could be substantiated by measuring the Standard Deviation of the Median Telomere Lengths, which together with the MTL would be lower than before. Or am I thinking in the wrong way here?
Something like this actually happened in a rather extreme fashion when I tried using AIV in my regimen. For reference I've included an extract from the excel chart which contain all my measurements.
I seem to remember a lab report published by Anthony, which stated that TA-65 at one time contained a measurable amount of AIV. This could possible mean TA-65 to some extent might have properties similar to taking AIV.
I remember it that way too. Mostly cycloastragenol with a little a4. Also, given that one is oil soluble and the other is water soluble, they might find their way to different parts of the body so supplementing with both may not be a bad idea. But not necessarily in the same capsule. That would let you mix the a4 with chitosan without risking compromise of the absorption of the cycloastragenol which might absorb better mixed with an oil.
Howard